Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tempest Therapeutics, Inc.

NASDAQ: TPST · Life Sciences · 12 alerts · CIK 1544227

Share price
$0.3418Close, Nov 16
Market cap
$6.83M
Shares outstanding
20MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tempest Therapeutics, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Shareholder Meeting

Tempest Therapeutics Shareholder Meeting

Tempest Therapeutics held its 2026 Annual Meeting of Stockholders on November 9, 2026, where shareholders elected two Class II directors and ratified Ernst & Young LLP as the independent auditor. Stockholders also approved two key financing-related proposals under Nasdaq rules, including the potential issuance of shares to Lincoln Park Capital Fund and shares issuable upon the exercise of warrants from a September 2026 private placement.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.